ESR1 and breast cancer: Exosome-secreted miR-22 from CD63+ CAFs downregulates estrogen receptor-α (ERα) and PTEN expression, which leads to nuclear AKT activation, suppression of cell apoptosis, and eventually tamoxifen resistance in breast cancer [129].